DM
David J Moss
Chief Executive OfficerDirector

David J Moss insider trades: Inmune Bio (INMB) stock buys and sales

Chief Executive Officer, Inmune Bio Last trade Sep 30, 2024 25 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2008
3
Companies
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where David reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 30, 2024INMB↑ Buy$53K
Sep 12, 2024INMB↑ Buy$49K
Mar 17, 2023INMB↑ Buy$16K
May 27, 2022INMB↑ Buy$69K
Nov 3, 2021INMB↓ Sell$21K
Oct 27, 2021INMB↓ Sell$42K
Oct 25, 2021INMB↓ Sell$23K
Jul 8, 2021INMB↓ Sell$502K
Aug 20, 2019INMB↑ Buy$17K
Jun 3, 2019INMB↑ Buy$60K
May 6, 2019INMB↑ Buy$45K
May 5, 2011TAEI↑ Buy$10K
Feb 1, 2008PGSI.OB↑ Buy$40K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About David J Moss's insider trades

David J Moss is Chief Executive Officer at Inmune Bio (INMB). Since Feb 1, 2008, David has reported 9 open-market purchases worth $359K and 4 sales worth $587K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (11 filings), option exercises (2 filings), other transactions (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every INMB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.